AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹283 Cr | ₹226 Cr | ₹173 Cr | ₹172 Cr | ₹157 Cr |
What is the latest Long Term Provisions ratio of AUROBINDO PHARMA ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹283 Cr |
| Mar2024 | ₹226 Cr |
| Mar2023 | ₹173 Cr |
| Mar2022 | ₹172 Cr |
| Mar2021 | ₹157 Cr |
How is Long Term Provisions of AUROBINDO PHARMA Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹283 Cr | 25.36 | |
| Mar2024 | ₹226 Cr | 30.67 | |
| Mar2023 | ₹173 Cr | 0.54 | |
| Mar2022 | ₹172 Cr | 9.34 | |
| Mar2021 | ₹157 Cr | - | |
Compare Long Term Provisions of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹80,705.1 Cr | -1.7% | 5.8% | 14.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,848.0 Cr | 11.6% | 0.7% | -0.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,697.0 Cr | 2.3% | 8.5% | 8.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,859.0 Cr | 1.8% | -1.8% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,421.0 Cr | 0.5% | 3.2% | 13.3% | Stock Analytics | |
| CIPLA | ₹105,811.0 Cr | 1.2% | 5.4% | -13.7% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | -1.7% |
5.8% |
14.7% |
| SENSEX | -1% |
2.2% |
-3.6% |
You may also like the below Video Courses